Status:
COMPLETED
Regenerative Medicine Approach to Nasal Reconstruction
Lead Sponsor:
Mayo Clinic
Conditions:
Nasal Surgical Procedures
Regenerative Medicine
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of this study is to gather information on the safety and effectiveness and compare nasal reconstruction standard planning versus 3D preoperative scanning/printing/planning.
Detailed Description
Patients with nasal defects from cancer, trauma, prior surgery, or birth often require complex reconstruction. Current techniques involve hand sketched skin templates and/or hand carved cartilage graf...
Eligibility Criteria
Inclusion
- Males or female, age range is ≥ 18 to ≤ 100, based on historical surgical experience.
- Patients undergoing nasal reconstruction.
- Patients will be identified from the Facial Plastic Surgery clinic of the PI.
Exclusion
- \- Patients \< 18 are excluded because these cases are in combination with providers from PCH and patients have shared/limited postoperative follow up as a result.
Key Trial Info
Start Date :
May 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2024
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05273060
Start Date
May 18 2022
End Date
December 19 2024
Last Update
July 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Arizona
Phoenix, Arizona, United States, 85054